Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

被引：21

作者：

Einsele, H. ^{[1
]}

Knop, S. ^{[1
]}

Vogel, M. ^{[2
]}

Mueller, J. ^{[3
]}

Kropff, M. ^{[4
]}

Metzner, B. ^{[5
]}

Langer, C. ^{[6
]}

Sayer, H. ^{[7
]}

Jung, W. ^{[8
]}

Duerk, H. A. ^{[9
]}

Salwender, H. ^{[10
]}

Wandt, H. ^{[11
]}

Bassermann, F. ^{[12
]}

Gramatzki, M. ^{[13
]}

Roesler, W. ^{[14
]}

Wolf, H-H ^{[15
]}

Brugger, W. ^{[16
]}

Engelhardt, M. ^{[17
]}

Fischer, T. ^{[18
]}

Liebisch, P. ^{[6
]}

Straka, C. ^{[19
]}

机构：

[1] Julius Maximilians Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[2] Janssen Cilag GmbH, Neuss, Germany

[3] Acromion GmbH, Frechen, Germany

[4] Univ Klinikum Munster, Munster, Germany

[5] Klinikum Oldenburg Klin Onkol & Hamatol, Oldenburg, Germany

[6] Univ Klinikum Ulm, Zentrum Innere Med, Ulm, Germany

[7] Univ Hosp Jena, Jena, Germany

[8] Onkol Univ Med Gottingen, Gottingen, Germany

[9] St Marien Hosp Hamm Knappenstr, Hamm, Germany

[10] Asklepios Klin Altona, Hamburg, Germany

[11] Med Klin 5 Hamatol & Onkol, Nurnberg, Germany

[12] Tech Univ Munich, Med Klin, Munich, Germany

[13] Univ Klinikum Schleswig Holstein, Kiel, Germany

[14] Univ Klinkum Erlangen, Erlangen, Germany

[15] Univ Hosp Halle, Halle, Saale, Germany

[16] Schwarzwald Baar Klinikum, Villingen Schwenningen, Germany

[17] Univ Freiburg, Freiburg, Germany

[18] Otto von Guericke Univ, Magdeburg, Germany

[19] Schon Klin Starnberger See, Berg, Germany

来源：

LEUKEMIA | 2017年 / 31卷 / 06期

关键词：

STEM-CELL TRANSPLANTATION; INDUCTION; THERAPY; PHASE-3;

D O I：

10.1038/leu.2017.83

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1463 / 1466

页数：5

共 50 条

[21] Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial
Muranushi, Hiroyuki
Kanda, Junya
Kobayashi, Masayuki
Maeda, Takeshi
Kitano, Toshiyuki
Tsuji, Masaaki
Ueda, Yasunori
Ishikawa, Takayuki
Nohgawa, Masaharu
Watanabe, Mitsumasa
Imada, Kazunori
Moriguchi, Toshinori
Itoh, Mitsuru
Ohno, Hitoshi
Yonezawa, Akihito
Hirata, Hirokazu
Arima, Nobuyoshi
Asagoe, Kohsuke
Anzai, Naoyuki
Nagata, Kayoko
Yasuno, Shinji
Kuwabara, Yoshihiro
Kitao, Hiromi
Kim, Ihhwa
Kawagishi, Kiyomi
Ueshima, Kenji
Tominari, Shinjiro
Nakayama, Takeo
Yamashita, Kouhei
Takaori-Kondo, Akifumi
HEMATOLOGY, 2022, 27 (01) : 239 - 248
[22] Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study)
Nakasone, Hideki
Terasako-Saito, Kiriko
Hirano, Teiichi
Wake, Atsushi
Shimizu, Seiichi
Kurita, Naoki
Yamazaki, Etsuko
Usuki, Kensuke
Akazawa, Kohei
Kanda, Junya
Minauchi, Koichiro
Yamamoto, Go
Tanimoto, Shiori
Kamoshita, Masaharu
Yokoyama, Yasuhisa
Miyaoka, Etsuo
Ota, Shuichi
Kako, Shinichi
Izutsu, Koji
Kanda, Yoshinobu
HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 202 - 209
[23] Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study
Chen, Runzhe
Zhang, Xiaoping
Gao, Chong
Luan, Chengxin
Wang, Yujie
Chen, Baoan
CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 373 - 380
[24] Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival
Jimenez-Zepeda, Victor H.
Reece, Donna E.
Trudel, Suzanne
Franke, Norman
Winter, Andrew
Chen, Christine
Tiedemann, Rodger
Kukreti, Vishal
LEUKEMIA & LYMPHOMA, 2014, 55 (10) : 2284 - 2289
[25] Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma
Aggarwal, Mukul
Agrawa, Narendra
Yadav, Neha
Verma, Priyanka
Ahmed, Rayaz
Mehta, Pallavi
Kapoor, Jyotsna
Bhurani, Dinesh
ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1869 - 1877
[26] Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple Myeloma
Schaefer, Eric W.
Kumar, Shaji
Dispenzieri, Angela
Allred, Jacob B.
Gertz, Morie A.
Lacy, Martha Q.
Rajkumar, S. Vincent
Mandrekar, Sumithra J.
CANCER, 2010, 116 (03) : 640 - 646
[27] Use of depth of response to predict progression-free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials
Mangal, Naveen
Salem, Ahmed Hamed
Menon, Rajeev M.
Freise, Kevin J.
HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 547 - 553
[28] Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse
Sidana, Surbhi
Tandon, Nidhi
Dispenzieri, Angela
Gertz, Morie A.
Buadi, Francis K.
Lacy, Martha Q.
Dingli, David
Fonder, Amie L.
Hayman, Suzanne R.
Hobbs, Miriam A.
Gonsalves, Wilson I.
Warsame, Rahma M.
Kourelis, Taxiarchis
Hwa, Yi Lisa
Kapoor, Prashant
Kyle, Robert A.
Leung, Nelson
Go, Ronald S.
Rajkumar, S. Vincent
Kumar, Shaji K.
LEUKEMIA, 2019, 33 (03) : 730 - 738
[29] Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response
Mina, Roberto
Petrucci, Maria Teresa
Corradini, Paolo
Spada, Stefano
Patriarca, Francesca
Cerrato, Chiara
De Paoli, Lorenzo
Pescosta, Norbert
Ria, Roberto
Malfitano, Alessandra
Musto, Pellegrino
Baldini, Luca
Guglielmelli, Tommasina
Gamberi, Barbara
Mannina, Donato
Benevolo, Giulia
Zambello, Renato
Falcone, Antonietta Pia
Palumbo, Antonio
Nagler, Arnon
Calafiore, Valeria
Hajek, Roman
Spencer, Andrew
Boccadoro, Mario
Bringhen, Sara
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (08) : 533 - 540
[30] Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma
Corso, Alessandro
Galli, Monica
Mangiacavalli, Silvia
Rossini, Fausto
Nozza, Andrea
Pascutto, Cristiana
Montefusco, Vittorio
Baldini, Luca
Cafro, Anna Maria
Crippa, Claudia
Cazzola, Mario
Corradini, Paolo
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 150 - 154

← 1 2 3 4 5 →